Cargando…
Repurposing Eltrombopag for Multidrug Resistant Staphylococcus aureus Infections
The continuous rise of antimicrobial resistance urgently demands new therapeutic agents for human health. Drug repurposing is an attractive strategy that could significantly save time delivering new antibiotics to clinics. We screened 182 US Food and Drug Administration (FDA)-approved drugs to ident...
Autores principales: | Lee, Hyunjung, Lee, Jaehoan, Hwang, Juchan, Park, Sinyoung, Kim, Namyoul, Kim, Kideok, Lee, Honggun, Shum, David, Jang, Soojin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615030/ https://www.ncbi.nlm.nih.gov/pubmed/34827309 http://dx.doi.org/10.3390/antibiotics10111372 |
Ejemplares similares
-
Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2022) -
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening
por: Benítez, Diego, et al.
Publicado: (2022) -
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015) -
Multidrug-Resistant Staphylococcus aureus in US Meat and Poultry
por: Waters, Andrew E., et al.
Publicado: (2011) -
Multidrug-Resistant Staphylococcus aureus, India, 2013–2015
por: Kumar, Mohit
Publicado: (2016)